Oxidoreductases, N-Demethylating
"Oxidoreductases, N-Demethylating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D010089
|
| MeSH Number(s) |
D08.811.682.662.582
|
| Concept/Terms |
Oxidoreductases, N-Demethylating- Oxidoreductases, N-Demethylating
- N-Demethylating Oxidoreductases
- Oxidoreductases, N Demethylating
- Demethylating Oxidoreductases, N
- N Demethylating Oxidoreductases
- N-Demethylases
- N Demethylases
|
Below are MeSH descriptors whose meaning is more general than "Oxidoreductases, N-Demethylating".
Below are MeSH descriptors whose meaning is more specific than "Oxidoreductases, N-Demethylating".
This graph shows the total number of publications written about "Oxidoreductases, N-Demethylating" by people in this website by year, and whether "Oxidoreductases, N-Demethylating" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oxidoreductases, N-Demethylating" by people in Profiles.
-
Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, Vachharajani N, Mitroka J. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. Drug Metab Dispos. 2005 Apr; 33(4):500-7.
-
Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. J Pharmacol Exp Ther. 2002 Oct; 303(1):323-32.
-
Prueksaritanont T, Vega JM, Rogers JD, Gagliano K, Greenberg HE, Gillen L, Brucker MJ, McLoughlin D, Wong PH, Waldman SA. Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects. J Clin Pharmacol. 2000 Nov; 40(11):1274-9.
-
McCrea J, Prueksaritanont T, Gertz BJ, Carides A, Gillen L, Antonello S, Brucker MJ, Miller-Stein C, Osborne B, Waldman S. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. J Clin Pharmacol. 1999 Dec; 39(12):1212-20.
-
Clot P, Albano E, Eliasson E, Tabone M, Aric? S, Israel Y, Moncada C, Ingelman-Sundberg M. Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology. 1996 Jul; 111(1):206-16.
-
Ross AD, Varghese G, Oporto B, Carmichael FJ, Israel Y. Effect of propylthiouracil treatment on NADPH-cytochrome P450 reductase levels, oxygen consumption and hydroxyl radical formation in liver microsomes from rats fed ethanol or acetone chronically. Biochem Pharmacol. 1995 Mar 30; 49(7):979-89.